_compressed.JPG)
IMA Zanasi 6F Automatic Encapsulator Pharma Encapsulation Good Condition
IMA
Details
-
CategoryPharma
-
Dimension102.0cm x 135.0cm x 182.0cm
-
Serial35051
-
Shipping TypeFedEx Ground
-
ManufacturingDoes Not Apply
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The IMA Zanasi 6F Automatic Encapsulator, manufactured in the United States by IMA, represents a advanced solution for encapsulation processes in pharmaceutical production. Operating in good condition, this encapsulator has passed initial power-on and basic functionality checks to ensure readiness for integration into your production line. Though comprehensive testing was not performed, no indications of malfunction were observed, and it shows only cosmetic wear from previous use. Included with the device is a user manual to facilitate setup and operation. Ideal for small to large manufacturing scales, it promises efficiency in encapsulating without compromising the integrity of the active ingredients.
Key Features
- Automatic encapsulation process
- Suitable for pharmaceutical production
- Includes user manual
- Good working condition with cosmetic wear
- Power/data cable included
Specifications
- Brand/Manufacturer: IMA
- Model: Zanasi 6F
- Condition: Good, with cosmetic wear
- Power/Data Cables: Included
- Actual Dimensions: Length 101.6 cm, Width 134.99 cm, Height 181.98 cm
- Shipping Dimensions: Length 121.92 cm, Width 162.07 cm, Height 218.47 cm
- Actual Weight: 771.618 lb
- Country of Origin: United States
Weight
Imperial: 925.94 Pounds
Metric: 420.0 Kilograms
Shipping Dimensions
Imperial: 48.0 lb x 63.77 lb x 85.98 lb
Metric: 121.92 cm x 161.98 cm x 218.39 cm
Harmonized Code
842240
Harmonized Code Details
The harmonized code 842240 pertains to machinery for packing or wrapping capsules, tablets, and similar products. Given the IMA Zanasi 6F's role in automatic encapsulation within the pharmaceutical industry, this classification is appropriate for accurately capturing its primary function within global trade frameworks.
Comments 0
There are currently no public comments.